Neurología
Servicio
Hospital Universitario Doctor Peset
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Doctor Peset (23)
2024
-
Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry
Neuromuscular Disorders, Vol. 34, pp. 1-8
-
Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis
Frontiers in Neurology , Vol. 15
-
XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (I)
Revista de neurologia, Vol. 79, Núm. 1, pp. 21-29
-
XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (II)
Revista de neurologia, Vol. 79, Núm. 2, pp. 51-66
2023
-
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193
2022
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
-
Expert-Agreed Practical Recommendations on the Use of Cladribine
Neurology and Therapy
2021
-
Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry
Journal of Clinical Medicine, Vol. 10, Núm. 19
-
XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (I)
Revista de neurologia, Vol. 72, Núm. 11, pp. 397-406
-
XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (II)
Revista de neurologia, Vol. 72, Núm. 12, pp. 433-442
2020
-
Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry
Epilepsia, Vol. 61, Núm. 6, pp. 1109-1119
-
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Frontiers in Neurology, Vol. 11
2019
-
MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy
Epilepsy and Behavior, Vol. 97, pp. 51-59
2018
-
Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study
Epilepsia, Vol. 59, Núm. 9, pp. 1740-1752
2017
-
Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: A prospective observational study
Journal of Translational Medicine, Vol. 15, Núm. 1
-
EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure
Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264
-
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series
Seizure, Vol. 48, pp. 53-56
-
Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)
Epilepsy Research
2016
-
Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study
Epilepsy Research, Vol. 126, pp. 201-210
2015
-
Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study
Clinical Drug Investigation, Vol. 35, Núm. 2, pp. 121-131